Literature DB >> 12446064

Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure.

Mark T Kearney1, Keith A A Fox, Amanda J Lee, Robin J Prescott, Ajay M Shah, Philip D Batin, Wazir Baig, Stephen Lindsay, Timothy S Callahan, William E Shell, Dwain L Eckberg, Azfar G Zaman, Simon Williams, James M M Neilson, James Nolan.   

Abstract

OBJECTIVES: The aim of this study was to explore the value of noninvasive predictors of death/mode of death in ambulant outpatients with chronic heart failure (HF).
BACKGROUND: Mortality in chronic HF remains high, with a significant number of patients dying of progressive disease. Identification of these patients is important.
METHODS: We recruited 553 ambulant outpatients age 63 +/- 10 years with symptoms of chronic HF (New York Heart Association functional class, 2.3 +/- 0.5) and objective evidence of left ventricular dysfunction (ejection fraction <45%, cardiothoracic ratio >0.55, or pulmonary edema on chest radiograph). After 2,365 patient-years of follow-up, 201 patients had died, with 76 events due to progressive HF.
RESULTS: Independent predictors of all-cause mortality assessed with the Cox proportional hazards model were as follows: a low standard deviation of all normal-to-normal RR intervals (SDNN); lower serum sodium and higher creatinine levels; higher cardiothoracic ratio; nonsustained ventricular tachycardia; higher left ventricular end-systolic diameter; left ventricular hypertrophy; and increasing age. Independent predictors of death specific to progressive HF were SDNN, serum sodium and creatinine levels. The hazard ratio of progressive HF death for a 10% decrease in SDNN was 1.06 (95% confidence interval [CI], 1.01 to 1.12); for a 2 mmol/l decrease in serum sodium, 1.22 (95% CI, 1.08 to 1.38); and for a 10 micromol/l increase in serum creatinine, 1.14 (95% CI, 1.09 to 1.19) (all p < 0.01).
CONCLUSIONS: In ambulant outpatients with chronic HF, low serum sodium and SDNN and high serum creatinine identify patients at increased risk of death due to progressive HF.

Entities:  

Mesh:

Year:  2002        PMID: 12446064     DOI: 10.1016/s0735-1097(02)02490-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  51 in total

1.  Prognosis in heart failure with preserved left ventricular systolic function: prospective cohort study.

Authors:  Philip A MacCarthy; Mark T Kearney; James Nolan; Amanda J Lee; Robin J Prescott; Ajay M Shah; W Paul Brooksby; Keith A A Fox
Journal:  BMJ       Date:  2003-07-12

2.  Heart rate turbulence for prediction of heart transplantation and mortality in chronic heart failure.

Authors:  Beata Sredniawa; Sylwia Cebula; Jacek Kowalczyk; Velislav N Batchvarov; Agata Musialik-Lydka; Anna Sliwinska; Aleksandra Wozniak; Michal Zakliczynski; Marian Zembala; Zbigniew Kalarus
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-07       Impact factor: 1.468

3.  Low serum sodium as a poor prognostic indicator for mortality in congestive heart failure patients.

Authors:  Andrew DeWolfe; Barbara Lopez; Lee M Arcement; Kathy Hebert
Journal:  Clin Cardiol       Date:  2010-11-22       Impact factor: 2.882

4.  Renal and anti-aldosterone actions of vasopressin-2 receptor antagonism and B-type natriuretic peptide in experimental heart failure.

Authors:  Lisa C Costello-Boerrigter; Guido Boerrigter; Alessandro Cataliotti; Gail J Harty; John C Burnett
Journal:  Circ Heart Fail       Date:  2010-02-22       Impact factor: 8.790

Review 5.  Cardiorenal syndrome: still not a defined entity.

Authors:  Carlo Longhini; Christian Molino; Fabio Fabbian
Journal:  Clin Exp Nephrol       Date:  2010-02-20       Impact factor: 2.801

Review 6.  Autonomic changes in patients with heart failure and in post-myocardial infarction patients.

Authors:  M P Frenneaux
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

7.  Glucose and haemoglobin in the assessment of prognosis after first hospitalisation for heart failure.

Authors:  J D Newton; I B Squire
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

8.  Rationale and design of the treatment of hyponatremia based on lixivaptan in NYHA class III/IV cardiac patient evaluation (THE BALANCE) study.

Authors:  William T Abraham; Juan M Aranda; John P Boehmer; Uri Elkayam; Edward M Gilbert; Stephen S Gottlieb; Gerd Hasenfuss; Marrick Kukin; Brian D Lowes; John B O'Connell; Luigi Tavazzi; Arthur M Feldman; Barry Ticho; Cesare Orlandi
Journal:  Clin Transl Sci       Date:  2010-10       Impact factor: 4.689

Review 9.  Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists?

Authors:  Gregory Valania; Manmeet Singh; Mara T Slawsky
Journal:  Curr Heart Fail Rep       Date:  2011-09

10.  Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.

Authors:  Pupalan Iyngkaran; Merlin Thomas; William Majoni; Nagesh S Anavekar; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2012-10-31       Impact factor: 2.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.